Using Dichoptic Therapy to Treat Intermittent Exotropia
ConditionExotropia Intermittent
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-7
SponsorVirginia Commonwealth University
About this trial
Intermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomized control trial and was not found to have a large benefit. More non-surgical treatment modalities are critical to improve the care in this condition.
Eligibility criteria
Qualifiers
Diagnosed with IXT
one eye that is their preferred eye
ages 4-7
distance control scores of <= 4
Disqualifiers
distance control scores of 5
patients with visual acuity with vision that is worse in one eye by greater than two lines
no preferred eye
patients who would be unable to tolerate wearing the headset for 1 hour/day, 6 days/week, for 12 weeks.
Trial design
Treatments tested in this trial
- Luminopia, a virtual reality headset
- Paper pre- survey
- Paper Survey
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov